Replies to post #485981 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Very true. At 600 patients for one year, multiplied by 200,000, that’s about 120 million to buy time until Eden.

[biosectinvestor]

That is with a small percentage of the factory space in use. And I would not presume that Eden/Flaskworks is not already well on its way to being certified for manufacturing.

I actually do not believe manufacturing is standing in the way of approval. Car-T companies are still using manual production and are already approved in the UK and can barely meet demand. I do not think it appears that DCVwx will be in the same position, and I think the MHRA likely is well on its way to knowing that to be the case. Even in the US, to get accelerated approval, you do not need all manufacturing to already be in place, you need to have the regulator comfortable that you have a plan to scale up. I think they probably have that with contingencies and more already.